Xenetic Biosciences, Inc. (Nasdaq: XBIO) to Ring The Nasdaq Stock Market Opening Bell
Mar 29, 2017 14:55 pm UTC| Business
ADVISORY, March 29, 2017 -- What:Xenetic Biosciences, Inc. (Nasdaq:XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel...
Mar 29, 2017 14:54 pm UTC| Business
CLEVELAND, March 29, 2017 -- McGlinchey Stafford PLLC is pleased to announce Mark S. Edelman, a Member in the firm’s Cleveland office, has been elected a Fellow of the American College of Consumer Financial Services...
HSN Launches Global Product Innovation Program, The Beauty Spy, With Chelsea Scott
Mar 29, 2017 14:54 pm UTC| Business
ST. PETERSBURG, Fla., March 29, 2017 -- Entertainment and lifestyle retailer, HSN, has partnered with TV personality and beauty industry professional Chelsea Scott, to launch The Beauty Spy. The program will appear...
Willis Towers Watson announces Decode Cyber Risk program at RIMS Conference
Mar 29, 2017 14:48 pm UTC| Business
ARLINGTON, Va., March 29, 2017 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, announced today its cyber risk program for the upcoming Risk Insurance Management Society...
Egalet Corporation (Nasdaq: EGLT) to Ring The Nasdaq Stock Market Closing Bell
Mar 29, 2017 14:48 pm UTC| Business
ADVISORY, March 29, 2017 -- What:Egalet Corporation (Nasdaq:EGLT), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and...
Ubiquiti Networks Launches UniFi® AC In-Wall 802.11ac Wi-Fi Access Point
Mar 29, 2017 14:45 pm UTC| Business
SAN JOSE, Calif., March 29, 2017 -- Ubiquiti Networks, Inc. (NASDAQ:UBNT) ("Ubiquiti") today announced the UniFi AC In-Wall Wi-Fi Access Point, designed to expand an Ethernet wall connection to also function as a...
Nymox Provides Update on Fexapotide Development
Mar 29, 2017 14:45 pm UTC| Business
HASBROUCK HEIGHTS, N.J., March 29, 2017 -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) provided an update today on the Company's development activities for Fexapotide Triflutate,its new drug for prostate enlargement....